Glucose-insulin-potassium infusion in patients with acute coronary syndrome without ST segment elevation

摘要

Effects of high-dose glucose-insulin-potassium (GIK) infusion have been studied in open randomized study on 43 patients with non-ST segment elevation acute coronary syndrome (NSTEACS). 24-hour GIK infusion can reduce myocardial injury and improve impaired contractility, demonstrates an anti-ischemic effect but is associated with increased risk of delayed negative cardiovascular events without surgical revascularization.